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Most viruses infect their hosts by crossing the mucosal surfaces of the respiratory, gastrointestinal, or genital
tracts, then spread—often through the bloodstream—to other organs; they are shed in bodily secretions to
reach new hosts. At each stage in the cycle of infection viruses surmount significant anatomic barriers. This
Minireview focuses on the role of intercellular junctions as barriers to virus dissemination, and the somewhat
paradoxical observation that several viruses, rather than evading these barriers, target them directly by using
junctional proteins as receptors.Introduction
At the cellular level, the first step in the virus lifecycle is attach-
ment to a receptor on the host cell membrane, which initiates
a series of events that culminates in release of the viral genome
into the cell (reviewed in Helenius, 2007). A cell’s susceptibility to
infection depends, in part, on its expression of an appropriate
receptor molecule. In a culture dish, a cell’s entire plasma
membrane may be accessible to virus; if an appropriate receptor
is expressed, a virus will find it. In vivo, however, tissues have
a complex architecture, and viruses cannot diffuse freely through
the body to reach their targets.
Tight intercellular junctions are an important barrier to viruses
as they cross the mucosal epithelium, disseminate through the
bloodstream, and spread to other hosts. This Minireview
discusses several examples from the recent literature that illus-
trate how viruses interact with—and make use of—junctional
proteins at various stages of their lifecycle.
The Mucosal Barrier, and Bypassing Tight Junctions
The mucosal epithelium, which serves to separate the body’s
interior from its environment, has likely evolved to exclude
viruses and other microorganisms. Ciliary motion and a thick gly-
cocalyx keep microbes away from the epithelial surface, and
secreted immunoglobulin and antimicrobial peptides inhibit
microbial growth. A dense apical actin web bars the internaliza-
tion of organisms that make their way through the apical plasma
membrane. And intercellular junctions prevent microbes from
passing between mucosal epithelial cells and entering the under-
lying tissues (see references in Bergelson [2003]).
The airways and intestine are lined by polarized epithelial cells,
with distinct apical and basolateral membrane domains
(Figure 1A, i). In electron micrographs, these domains are sepa-
rated by tight junctions, intercellular contact sites where
membranes are so closely apposed that there appears to be no
intercellular space. Tight junctions form a seal between adjoining
cells, regulating the paracellular movement of molecules, inflam-
matory cells, and microbes; in addition, they prevent the intermix-
ture of apical and basolateral membrane components, thus main-
taining the integrity of the distinct domains.As one might expect, some viruses bind receptors expressed
on the apical surface (such as the receptor for human influenza
viruses, a-2-6-linked sialic acid). However, many other viruses
interact with receptors on the basolateral surface; for these
viruses, the tight junction, by blocking virus access to the baso-
lateral membrane, may be an important barrier to infection. This
became evident during efforts to use viral vectors for gene
delivery to the airways, when it was recognized that transduction
was efficient only when receptors were exposed as a result of
trauma or disruption of tight junctions.
Despite these obstacles, viruses do cross mucosal surfaces
(Figure 1B). If they do not attach to apical receptors and infect
cells directly, they may take advantage of abrasions or gaps in
the mucosa, or they may be transported through junctions by
leukocytes or by the extended membrane processes of submu-
cosal dendritic cells. They may be transcytosed directly through
epithelial cells, or through specialized M cells, which sample
environmental antigens and present them to underlying
lymphoid tissue in the airway or intestine (Bergelson, 2003).
Given the many ways that viruses can bypass junctional
barriers, it has been surprising that a number of viruses target
the junctions themselves during the entry process, using tight
junction proteins as receptors.
Tight Junction Structure
The central components of the tight junction areadhesive proteins
that interact with partners on the neighboring cell membrane,
forming the intercellular seal (Figure 1C) (reviewed in Aijaz et al.
[2006]). Claudins and occludin are multipass transmembrane
proteins with loops that extend into the intercellular space; junc-
tion adhesion molecules (JAMs) and the closely related coxsack-
ievirus and adenovirus receptor (CAR) are immunoglobulin family
members with single transmembrane domains. Beneath the
plasma membrane, multivalent scaffolding proteins interact with
the cytoplasmic domains of the transmembrane proteins, forming
a dense array that links the junction to the actin cytoskeleton and
to a variety of intracellular signaling molecules. Each of the trans-
membrane proteins—claudins, occludin, CAR, and JAM—serves
as a receptor or coreceptor for one or more viruses (Table 1).Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 517
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(A) Membrane domains and tight junctions in polarized cells. (i) In polarized epithelium, tight junctions (TJs) separate the apical membrane (in contact with the
airway or intestinal lumen) from the basolateral surface. Adherens junctions (AJ) are just below the TJ. (ii) In the vascular endothelium, TJ and adherens junctions
intermingle at cell-cell contacts. (iii) In the liver, hepatocytes are arranged in cords, surrounded on each side by sinusoidal vessels; the sinusoidal endothelium is
highly permeable, so the basal surfaces of hepatocytes are essentially in contact with plasma. The apical cell membranes, bounded by TJs, form the canaliculi
through which bile is excreted.
(B) Potential mechanisms by which viruses avoid tight junctions. (i) Attachment to apical receptor. (ii) Passage through epithelial break or endothelial fenestration.
(iii) Transcytosis across epithelial cell or M cell. (iv) Virus associates with leukocyte, which passes through junction.
(C) Transmembrane proteins in the tight junction. The closely apposed membranes of the tight junction are held together by adhesive interactions between the
extracellular domains of claudins, occludin, and members of the junction adhesion molecule family (including JAM and CAR). On the cytoplasmic face of the
junction, multidomain scaffolding proteins, including ZO-1 and ZO-2, organize the transmembrane proteins and link them to intracellular signaling pathways
and the actin cytoskeleton. Below the tight junction, adherens junctions are formed by transmembrane nectins and cadherens. Nectin serves as a receptor
for herpes simplex virus.CBV Use CAR, DAF, and Occludin to Infect Polarized
Epithelium
CAR was first identified as a receptor for two unrelated human
pathogens, adenoviruses and coxsackie B viruses (for refer-
ences, see Coyne and Bergelson [2006]). The subsequent recog-
nition that CAR is a component of the tight junction helped
explain the puzzling observation that adenoviruses, although
they commonly cause respiratory illness, do not easily infect
polarized respiratory epithelium: because CAR is confined to
tight junctions in polarized cells, it is not accessible to viruses
at the apical cell surface. Similarly, although CAR expression
on nonpolarized cells allows coxsackie B virus (CBV) to attach
and infect, polarized epithelium resists CBV infection in vitro,
unless junctions are disrupted and CAR is exposed.
Coxsackieviruses are transmitted by the oral route and are
believed to cross the intestinal mucosa before spreading to other
sites in the body. If the primary receptor is hidden in tight junc-
tions, how does virus in the intestinal lumen initiate infection? It
might bypass the epithelium entirely, crossing M cells by trans-
cytosis. However, it appears that CBV has evolved to use an
additional receptor molecule, and a complex entry mechanism,
to infect polarized epithelial cells.
A subset of CBV isolates bind to decay accelerating factor
(DAF), a protein that is highly expressed on the apical surface518 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.of polarized cells, and DAF-binding CBVs readily infect polarized
epithelium. By engaging DAF on the cell surface, CBV initiates
intracellular signals (transmitted through Abl kinase and Rac
GTPase) that lead to rearrangements of the apical actin network
and movement of virus to the tight junction (Coyne and Bergel-
son, 2006). At the junction, virus interacts with CAR, and then
moves into the cell to initiate infection.
Many viruses have been found to use more than one receptor
(Helenius, 2007). Distinct receptor interactions may be required
for specific events in the process of virus entry; for example,
one receptor may permit virus to attach, and a second may
trigger the events that release the viral genome into the cell.
Alternative receptors may also allow a virus to expand its tropism
and infect a variety of cell types. For CBV infection of polarized
cells, a secondary receptor, DAF, permits virus to surmount
a specific anatomic barrier—the sequestration of CAR in the tight
junction.
Remarkably, CBV entry depends on an additional tight junc-
tion protein, occludin (Coyne et al., 2007). As virus enters the
cell, occludin is internalized as well, moving from the TJ to vesi-
cles within the cytoplasm (in contrast, CAR and DAF remain
behind). Virus entry and occludin internalization appear to be
closely coupled. Occludin is internalized in macropinosomes,
vesicles responsible for receptor-independent uptake of fluid
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Virus Junction Protein Other Receptors References
Adenovirus 2, 5 CAR integrins (avb3), sialic acid, factor X Zhang and Bergelson, 200510; Waddington et al., 20088
Coxsackievirus B3 CAR, occludin DAF, Heparan sulfate Coyne and Bergelson, 20062; Coyne et al., 20073;
Zautner et al., 20039
Reovirus JAM Sialic acid, (? others) Antar et al., 20091; Forrest and Dermody, 20034
Feline calicivirus JAM Makino et al., 20065
Hepatitis C virus Claudin, occludin CD81, SRBI, LDL-R, DC-SIGN, L-SIGN Ploss et al., 20096; von Hahn and Rice, 20087
1 Antar, A. A., Konopka, J. L., Campbell, J. A., Henry, R. A., Perdigoto, A. L., Carter, B. D., Pozzi, A., Abel, T. W., and Dermody, T. S. (2009). Junctional
adhesion molecule-A is required for hematogenous dissemination of reovirus. Cell Host Microbe 5, 59–71.
2 Coyne, C. B., and Bergelson, J. M. (2006). Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell
124, 119–131.
3 Coyne, C. B., Shen, L., Turner, J. R., and Bergelson, J. M. (2007). Coxsackievirus entry from epithelial tight junctions requires occludin and the small
GTPases Rab34 and Rab5. Cell Host Microbe 2, 181–192.
4 Forrest, J. C., and Dermody, T. S. (2003). Reovirus receptors and pathogenesis. J. Virol. 77, 9109–9115.
5 Makino, A., Shimojima, M., Miyazawa, T., Kato, K., Tohya, Y., and Akashi, H. (2006). Junctional adhesion molecule 1 is a functional receptor for feline
calicivirus. J. Virol. 80, 4482–4490.
6 Ploss, A., Evans, M. J., Gaysinskaya, V. A., Panis, M., You, H., de Jong, Y. P., and Rice, C. M. (2009). Human occludin is a hepatitis C virus entry factor
required for infection of mouse cells. Nature 457, 882–886.
7 von Hahn, T., and Rice, C. M. (2008). Hepatitis C virus entry. J. Biol. Chem. 283, 3689–3693.
8 Waddington, S. N., McVey, J. H., Bhella, D., Parker, A. L., Barker, K., Atoda, H., Pink, R., Buckley, S. M., Greig, J. A., Denby, L., et al. (2008). Adeno-
virus serotype 5 hexon mediates liver gene transfer. Cell 132, 397–409.
9 Zautner, A. E., Korner, U., Henke, A., Badorff, C., and Schmidtke, M. (2003). Heparan sulfates and coxsackievirus-adenovirus receptor: each one
mediates coxsackievirus B3 PD infection. J. Virol. 77, 10,071–10,077.
10 Zhang, Y., and Bergelson, J. M. (2005). Adenovirus receptors. J. Virol. 79, 12,125–12,131.and solutes, and agents that block macropinocytosis block both
occludin internalization and virus entry. Virus entry depends on
caveolin, a protein required for caveolar endocytosis, and cav-
eolin is likewise important for occludin internalization. Although
it is not clear that occludin and virus enter together from the tight
junction, they can be observed together in vesicles within the
cytoplasm. Furthermore, siRNA depletion of occludin blocks
virus entry and infection.
Occludin does not appear to interact directly with virus at the
cell surface. How does it contribute to virus entry? One possi-
bility is that CBV makes use of cellular mechanisms normally
involved in TJ remodeling, and manages to enter the cell with
occludin. Inflammation and changes in the extracellular environ-
ment can cause changes in junctional permeability, sometimes
associated with the endocytosis of one or more junctional
proteins (Yu and Turner, 2008). Considering that the dual require-
ment for caveolin and macropinocytosis in endocytosis of TJ
proteins has not previously been observed, an alternative possi-
bility is that occludin serves as a scaffold to recruit or anchor
signaling or regulatory molecules at the TJ during virus entry.
Hepatitis C Virus Infection Depends on Claudins
and Occludin
Hepatitis C virus (HCV), a major cause of chronic hepatitis, is
a small, enveloped virus that replicates almost exclusively in
hepatocytes (reviewed in von Hahn and Rice [2008]). In the
bloodstream, HCV is closely associated with plasma lipoproteins
(LDL and HDL), and lipoprotein receptors as well as glycosami-
noglycans bring the virus in close proximity to hepatocytes. On
the virion surface, the envelope glycoproteins E1 and E2 form
a dimer that mediates direct interaction with cellular receptors.
Soluble forms of E2 have been used to identify two receptor
molecules on hepatoma cells—CD81, a member of the tetraspa-nin family, and the scavenger receptor SRBI, a receptor for
HDL-associated cholesterol—and a variety of evidence indi-
cates their importance in HCV infection.
Hepatocytes are specialized epithelial cells arranged in thin
sheets, with basal membranes in contact on two sides with
blood in the sinusoidal spaces (Figure 1A, iii); these basal
membranes are responsible for the exchange of nutrients and
plasma proteins with sinusoidal blood. The apical membranes
are involved in the excretion of bile, and the apical membranes
of adjoining cells—sealed by tight junctions—make up the canal-
iculi through which bile is secreted. HCV entering the liver from
the bloodstream is delivered to the basal surfaces of hepato-
cytes, where SRBI and CD81 are highly expressed (Reynolds
et al., 2008).
Yet CD81 and SRBI are not sufficient to permit infection.
Remarkably both claudins (Evans et al., 2007; Zheng et al.,
2007) and occludin (Ploss et al., 2009) are also essential for
HCV to infect. Expression of human occludin and claudin-1, in
combination with CD81 and SRBI, permits HCV entry into other-
wise impervious mouse fibroblasts, although viral RNA replica-
tion is not observed in murine cells (Ploss et al., 2009). Depletion
of either claudin or occludin with siRNA prevents infection of
susceptible human hepatoma cell lines, indicating that both
proteins are required for infection (Evans et al., 2007; Liu et al.,
2009; Ploss et al., 2009).
CD81, SRBI, claudin, and occludin are all expressed on hepa-
tocytes, although none of them is expressed exclusively in liver.
It is not clear whether the specific tropism of HCV for the liver
results from the unique combination of receptors found on hepa-
tocytes, or from other factors. Nor is it clear how claudin and
occludin facilitate HCV infection. Both proteins are capable of
binding HCV glycoproteins, as demonstrated in coprecipitation
experiments (Liu et al., 2009; Yang et al., 2008), so it is likelyCell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 519
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requires internalization of the virion into endosomes, and fusion
of the viral envelope with host membranes, a process that
depends on low endosomal pH. Cells engineered to express
HCV E1/E2 have been shown to fuse with claudin-expressing
cells, in a pH-dependent process, suggesting that claudin acts
to envelope fusion (Evans et al., 2007).
Claudin and occludin have been reported to localize specifi-
cally to the tight junctions surrounding canaliculi (Takakuwa
et al., 2002), although claudin may also be present on the basal
and lateral membranes (Reynolds et al., 2008). It is not certain
whether HCV must move to the tight junction to interact with
claudin and occludin, or whether virus is endocytosed with clau-
din or occludin from the junction itself. HCV is difficult to obtain in
large amounts, and it has not yet been possible to observe
directly the movements of virus particles. It is important to note
that liver cells in culture do not truly reflect the anatomy of the
liver, in which tight junctions surround bile canaliculi. However,
in cultured hepatoma cells, engagement of CD81—by antibody
or by soluble HCV E2—activates Rho GTPase and causes actin
rearrangements that deliver CD81 and E2 to intercellular junc-
tions (Brazzoli et al., 2008). There is an obvious similarity here
to the movement of CBV across the apical surface of polarized
intestinal epithelium. It remains to be determined whether the
similarity is superficial, or whether the entry processes of HCV
and CBV share deeper similarities.
Reovirus Needs JAM for Hematogenous Spread
Tight junctions are also a prominent feature of the endothelial
cells that line blood vessels and lymphatic vessels (Figure 1A, ii).
Among its other functions, the vascular endothelium regulates
the exchange of macromolecules and solutes between the intra-
vascular and extravascular fluid compartments (reviewed in Baz-
zoni and Dejana [2004]). Some vessels, such as the sinusoids of
the liver, have small openings (fenestrae) that permit free diffusion
between the blood and interstitial fluid. Others are highly imper-
meable: in the small vessels of the brain, tight junctions between
endothelial cells create the blood-brain barrier, which prevents
solutes (and microorganisms) in the bloodstream from entering
the central nervous system. Although many viruses are trans-
ported through the bloodstream, the mechanism by which they
cross the endothelium is not understood. Recent observations
with reovirus suggest that specific receptors may be required.
Reovirus is a murine pathogen that is transmitted by the oral
route, crossing the intestine and disseminating to the brain and
other organs to cause disease (eviewed in Forrest and Dermody
[2003]); some reovirus types move to the brain through neurons,
but others spread by the hematogenous route. The major reovirus
receptor is the tight junctionprotein JAM-A.Somereovirus isolates
also bind to sialic acid. It is not known whether, as is the case with
coxsackieviruses and CAR, the localization of JAM-A to the tight
junction is a barrier to reovirus infection of polarized epithelial cells,
or whether sialic acid serves a DAF-like function in permitting virus
attachment to JAM-deficient apical membranes.
Recent work with JAM-A-deficient (JAM-A/) mice demon-
strates a critical role for JAM-A in the hematogenous dissemina-
tion of reovirus (Antar et al., 2009). JAM-A/ mice, unlike
wild-type mice, do not develop CNS symptoms when exposed
to the virus by the oral route, and no virus is recovered from520 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.the brain. However, virus replicates to high titer when inoculated
directly into the brain, and JAM-A/ primary neurons are
susceptible to infection in vitro, indicating that JAM is not
required directly for infection of neurons in the brain, and sug-
gesting that additional reovirus receptors remain to be identified.
Virus replicates to normal levels in the intestine, but little virus is
detectable in the bloodstream, suggesting further that JAM is
dispensable for primary infection in the intestine but plays an
important role in virus entry into the bloodstream and hematog-
enous spread. JAM-A/ primary endothelial cells resist infec-
tion in vitro, suggesting the possibility that JAM-A expression
in the endothelium is essential for virus spread.
The mechanism by which virus enters the bloodstream and
JAM’s specific function are uncertain. One possibility is that
JAM permits reovirus to infect endothelial cells, so that viremia
results from replication in the endothelium itself; if this is the
case, the virus must gain access to JAM on the basolateral cell
surface, or find its way to JAM within tight junctions. Interaction
with JAM on the basal cell surface may permit transcytosis, so
that virus moves through the endothelium without causing infec-
tion. JAM is known to be important for the movement of leuko-
cytes through endothelial tight junctions, and it is possible that
reovirus is carried into vessels by migrating leukocytes, or that
JAM regulates junctional permeability to permit free viral parti-
cles to pass though.
It is also conceivable that endothelial JAM is not required
specifically for entry into the bloodstream, but that JAM medi-
ates some unrecognized step in infection that follows replication
in the intestine and precedes the onset of viremia. If JAM expres-
sion on the endothelium is, in fact, required for viremia, it is also
possible that JAM is required for the virus to leave the blood-
stream, crossing the blood-brain barrier. Tissue-specific gene
deletion, ablating JAM expression specifically in endothelial
cells, or even in brain microvascular cells, may make it possible
to define more precisely where and how JAM functions.
A Basolateral Epithelial Cell Receptor Is Required
for Measles Virus Spread
Measles virus is transmitted by the respiratory route and has long
been believed to replicate in the respiratory epithelium before
disseminating through the bloodstream. However, the measles
virus receptor, CD150, is not expressed on respiratory epithelial
cells, and measles virus selectively infects respiratory epithelium
through the basolateral surface by binding to an unidentified
basolateral receptor (Leonard et al., 2008). Ablating the capacity
of measles virus to interact with the epithelial cell receptor does
not prevent the virus from infecting by the respiratory route, and
causing disease. Thus, infection of respiratory epithelium does
not appear to be essential in the first stages of measles virus
infection; entering virus may bypass the epithelium and directly
infect lymphocytes or dendritic cells expressing CD150.
However, although animals infected with the receptor-ablated
virus become ill, they do not shed virus in their respiratory secre-
tions, suggesting that interaction with the basolateral receptor
and replication in polarized epithelium are essential for virus
shedding into the airway. Because measles virus is spread by
the respiratory route, it appears that airway mucosa and airway
tight junctions function as a barrier, not to initial infection, but
during transmission to new hosts.
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The architecture of specific tissues imposes constraints on
viruses as they initiate infection, disseminate through the body,
and are transmitted from person to person. Viruses have undoubt-
edly evolved specific molecular mechanisms to do all these
things, capitalizing on their longstanding and intimate association
with normal cell biological processes. What we have learned so far
about how viruses interact with intercellular junctions provides
some insight into how complex the virus lifecycle really is.
It is not clear why viruses should target junctional proteins for
entry, given that other routes are available. One possibility is that
interactionwith junctional receptorsdirectsviruses intoadesirable
endocytic pathway, but it does not appear that coxsackievirus,
reovirus, and hepatitis C virus all use the same endocytic mecha-
nismfor entry.Anotherpossibility is that the innate immunesystem
is adapted to detect organisms at the apical surface, so that entry
from the tight junction allows viruses to evade immune defenses.
We do not yet know a great deal about how components of the
innate system are compartmentalized in polarized cells. However,
RIG-I, an important sensor of viral RNA, is concentrated at tight
junctions (Mukherjee et al., 2009), suggesting that the junctions
are not without defenses. When we understand why coxsackievi-
rus and hepatitis C virus need occludin to enter cells, how JAM
permits virus spread from the intestine to the bloodstream, and
how measles virus crosses the epithelium, we will know a great
deal more—about both viruses and cells—than we do now.
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